✦ LIBER ✦

Prednisone inhibits the efficacy of recombinant human growth hormone in pediatric renal transplant recipients

✍ Scribed by Elizabeth Ingulli; Anup Singh; Shoreh Moazami; Amir Tejani

Publisher: Springer
Year: 1994
Tongue: English
Weight: 90 KB
Volume: 8
Category: Article
ISSN: 0931-041X
DOI: 10.1007/bf00868286

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of recombinant human growth h

The effect of recombinant human growth hormone on responses to alloantigens in the pediatric transplant patient

✍ Mark R. Benfield; Angie Vail; F. Bryson Waldo; R. Pat Bucy; Edward C. Kohaut 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 329 KB

Recombinant human growth hormone post-re

Recombinant human growth hormone post-renal transplantation in children: A randomized controlled study of the NAPRTCS

✍ Fine M.D., Richard N.; Stablein, Donald; Cohen, Arthur H.; Tejani, Amir; Kohaut, 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

## Background: Growth retardation persists in renal allograft recipients despite successful transplantation. the etiology is multi-factorial including the adverse effects of corticosteroids, suboptimal allograft function, and perturbations of the gh/gf axis. recombinant human growth hormone (rhgh)

Inhibition of the growth of caki-I human

Inhibition of the growth of caki-I human renal adenocarcinoma in Vivo by luteinizing hormone-releasing hormone antagonist cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II

✍ Andreas Jungwirth; Andrew V. Schally; Gabor Halmos; Kate Groot; Karoly Szepeshaz 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views

## Background: Metastatic or recurrent renal cell carcinoma (rcc) is a therapeutic challenge because it is resistant to chemotherapy and external radiotherapy. no uniformly effective therapeutic agents are available for the management of patients with rcc. hormones and growth factors may play a rol